GMED
Globus Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$74.08
−0.11%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$73.74
From 52W high−23.49%
Volume2.90M
Market cap$9.95B
P/E (TTM)18.7x
P/S (TTM)3.2x
Div yield—
Key dataSep 18, 2026
Open
$73.74
From 52W high
−23.49%
Volume
2.90M
Market cap
$9.95B
ValuationView details →
P/E (Fwd)
14.5x
EV/EBITDA
10.8x
P/E (TTM)
18.7x
RSI (14)
36.1
MomentumView details →
1D Return
−0.11%
YTD Return
−14.77%
SummaryUpdated Jun 1, 2026
Globus Medical, Inc. (NYSE:GMED) is a medical device company founded in 2003 and headquartered in Audubon, Pennsylvania. The company went public in 2012 and has grown through both organic expansion and strategic acquisitions to become a major player in the musculoskeletal medical device market. In September 2023, Globus completed a transformative merger with NuVasive, significantly expanding its product portfolio and global reach. The company has evolved from a spine-focused specialist into a comprehensive musculoskeletal solutions provider, offering products for spine, trauma, orthopedics, and enabling technologies including robotic surgical systems.
Similar companies
Latest newsMore news →